The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.
J Med Virol
; 2022 Nov 29.
Article
in English
| MEDLINE | ID: covidwho-2232773
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
/
Variants
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Jmv.28359
Similar
MEDLINE
...
LILACS
LIS